Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from PFE

3 Stocks You Can Buy Now and Hold Onto for the Next Decade

Sticky inflation, robust spending, and resilient job growth have dwindled the likelihood of a Fed pivot and rekindled recessionary concerns. Amid rising market volatilities, quality stocks Pfizer (PFE), Hershey (HSY), and Bluegreen Vacations Holding (BVH) might be wise portfolio additions to hold on to for the next decade. Read on….

StockNews.com

3 Bargain Stocks to Buy Before the Crowd Catches On

A resilient economy and sticky inflation could lead Fed officials to hike interest rates higher than anticipated in the central bank’s next meeting. Although markets have been highly volatile amid concerns over the potential rate hikes and other macro headwinds, this has created an attractive opportunity for investors to scoop…

StockNews.com

4 Pharma Stocks to Buy Now for the Long Haul

The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks You Won't Have Regrets About Buying in 2023

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

StockNews.com

The 3 Best Stocks to Buy Now for Long-Term Investors

As inflation is still at an alarmingly high level, the Fed is expected to continue with its rate hikes this year. However, experts see chances of the economy evading a recession. Therefore, it could be wise to buy quality stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Walmart (WMT) now…

StockNews.com

3 Cash-Rich Dividend Stocks to Add to Your Portfolio Today

While inflation has been cooling, the jobs market remains tight. This could prompt the Fed to raise the benchmark rates more than many projected, leading to a recession this year. Amid this backdrop, investors could look to stabilize their portfolios by adding cash-rich dividend stocks Pfizer (PFE), BHP Group (BHP),…

StockNews.com

The No. 1 Pharma Stock to Buy for the Long Haul

Despite lingering macro disruptions, Street analysts expect pharma stock Pfizer (PFE) to gain double digits in the near term. Moreover, it pays a reliable dividend. Given its robust fundamentals, I think PFE might be an ideal buy for the long haul. Keep reading.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

The Best Stock to Invest $1,000 in Right Now

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

StockNews.com

3 Cream-of-the-Crop Stocks to Buy Today

With Russia’s plans to cut crude oil production threatening to tip an interest-rate-paranoid market into a fresh bout of volatility and sell-off, shares of fundamentally strong and profitable businesses, such as Taiwan Semiconductor Manufacturing Company (TSM), Walmart (WMT), and Pfizer (PFE), seem to be good investments now. Continue reading….

StockNews.com

2 Dividend Stocks to Buy in 2023 for a Stable Income Stream

Although the Fed is expected to go slow with rate hikes, they are not expected to end anytime soon. Moreover, the possibility of a recession cannot be ruled out yet. Given the uncertainties, fundamentally sound dividend stocks Pfizer (PFE) and Sisecam (SIRE) could be a solid addition to your portfolio…

StockNews.com

The Most Active Stocks to Buy on Wall Street This Week

Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly found takers on Wall Street. Read on….

StockNews.com

The Safest Stock to Buy on Wall Street Right Now

With the recent market rally hinged on hopes of an end to the Fed’s hawkishness in the foreseeable future, strong fundamentals of Pfizer (PFE) for excellent value could help investors secure decent risk-adjusted returns on their investments. Read on….

StockNews.com

3 Stocks to Buy if You're Building a Portfolio From Scratch

Shares of Pfizer (PFE), Centene (CNC), and Kellogg (K) could provide a solid foundation to new portfolios for sustained wealth creation, given the fundamental strength, consistent profitability, and resilient demand of these companies. Continue reading….

StockNews.com

3 Stocks That Could Help You Beat the Market in 2023

Looming recession fears, the Federal Reserve’s persistent monetary tightening plans, and stubbornly high inflation continue to impact investor sentiment. Hence, it could be wise to add fundamentally sound stocks Pfizer (PFE), Rio Tinto (RIO), and Lockheed Martin (LMT) to beat the market fluctuations this year. Continue reading….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

The Best Healthcare Stock on Wall Street to Buy Now

Pfizer (PFE) topped Wall Street’s EPS and revenue estimates in the third quarter. Moreover, the company updated its guidance for fiscal 2022. Analysts expect the stock to rise more than 16% in the near term. Therefore, it could be wise to buy the stock now. Keep reading….

StockNews.com

3 Top Pharma Stocks to Buy for the Long Haul

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

Manchester Evening News

Greater Manchester MP calls for flagship Atom Valley site to be thrown out of masterplan

Places for Everyone - the conurbation’s controversial long-term strategy for jobs and homes - is currently undergoing a public examination as part of the process towards it being signed off by the government.

StockNews.com

3 Stocks to Buy Right Now if You Want to Retire Early

The Fed’s indication to keep raising interest rates through this year and looming recession fears will likely keep the stock market under pressure for the near term. Therefore, investors looking for stability amid an uncertain macroeconomic environment could consider buying fundamentally strong dividend-paying healthcare stocks Johnson & Johnson (JNJ), Pfizer…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

These Are the 3 Best Stocks on Wall Street to Buy Now

Although inflation moderated for the sixth consecutive month in December, a recession is still likely as the Fed is expected to keep raising rates this year. Amid an uncertain economic backdrop, fundamentally strong and popular stocks on Wall Street, Microsoft (MSFT), Pfizer (PFE), and AT&T (T), could make ideal additions…

StockNews.com

3 Stocks Investors Should Pour Their Money Into in 2023

While inflation has been showing signs of cooling recently, it is still far beyond the Fed’s target rate. Consequently, the Fed is expected to keep raising the interest rates for some time, fueling the chances of a global recession. Therefore, it could be wise to invest in well-performing stocks Pfizer…

StockNews.com

The 4 Most Attractive Long-Term Stock Picks

With the Fed expected to keep rates higher throughout this year, the odds of the economy tipping into a recession are rising. Amid ongoing macroeconomic uncertainties, investors may consider buying companies with reliable performance over the years for solid long-term returns. To that end, Pfizer (PFE), Johnson & Johnson (JNJ),…

StockNews.com

2 Stocks That Can Protect Your Portfolio From a Recession

Amid widespread macro headwinds, recession odds are rising. Moreover, the latest job report shows signs of decelerating payroll growth. Therefore, we think reliable dividend-paying stocks Pfizer (PFE) and Walmart (WMT) could be ideal buys to protect your portfolio amid the recessionary pressures. Keep reading….

StockNews.com

Investing Champion Leif Soreide Notes Biotech Stocks May Be Countercyclical

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

StockNews.com

1 Stock That Would Be an Excellent Addition to Your Portfolio for Years to Come

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…

StockNews.com

3 Stocks to Help You Get Through Today's Market Fear

Instead of a Santa Claus rally, the market continues to experience volatility at the end of the year with uncertainties surrounding the reopening of the Chinese economy and a looming recession due to seemingly unending interest rate hikes. Given this backdrop, loading up on fundamentally strong stocks Walmart (WMT), Pfizer…

1 … 7 8 9 10

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

722 stories

Santa Claus

688 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.